Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:24 AM ET 8-K
Loan & Debt Millrose Properties, Inc. MRP

Millrose Properties $1B Debt Financing

Millrose Properties announced a private offering of $1.0 billion in senior notes, split into two $500 million tranches due in 2029 and 2031. The company intends to use the proceeds, along with a $500 million term loan draw, for general corporate purposes, including potential homesite acquisitions related to the Dream Finders and Beazer Homes merger and the repayment of $850 million in revolving credit facility debt.

Value
$1B
Term
through 2031
8:22 AM ET Form 4
Insider Buying Bank Bradesco BBD

Bank Bradesco Insider Denise Pauli Pavarina Buys $843K of Stock

Denise Pauli Pavarina bought 46,874 shares of Bank Bradesco at $17.98 a share, worth $843K in total on Sep 18, 2026. Shares held after the trade: 412,864 (+12.8%).

Value
$843K
Shares
46,874
Price
$17.98
Holding change
+12.8%
Trade date
Sep 18, 2026
8:20 AM ET 8-K
Loan & Debt LandBridge Co LLC LB

LandBridge Co $100M Debt Financing

LandBridge Company LLC's subsidiary, DBR Land Holdings LLC, has launched a private placement offering of $100 million in additional 6.250% Senior Notes due 2030. The proceeds from the offering are intended to be used to repay a portion of the outstanding borrowings under the company's revolving credit facility.

Value
$100M
Term
due 2030
8:15 AM ET 8-K
Business Update i-80 Gold Corp. IAUX

i-80 Gold Business Update

i-80 Gold Corp. announced a positive feasibility study for its Granite Creek Underground project in Nevada, reporting an initial mineral reserve of 556,500 ounces of gold and an after-tax NPV of $118 million. The company also released initial assay results from its Mineral Point open pit project, including a step-out hole showing 1.33 g/t Au over 225.6 meters. These updates support the company's strategy to feed its Lone Tree processing plant, which is expected to be operational by late 2027.

Term
9 years
8:15 AM ET 8-K
Leadership Change General Electric Co GE

General Electric Leadership Change

GE Aerospace announced that its Board of Directors has appointed Wesley Bush as the new independent Lead Director, succeeding Tom Horton who has served in the role since 2018. Additionally, the company reported that Judson Althoff, who joined the Board in June 2024, has been appointed to the Audit Committee.

8:08 AM ET 8-K
Investor Meeting RTB Digital, Inc. RTB

RTB Digital Investor Meeting

RTB Digital (Roundtable) issued a 2027 operating forecast projecting $102.1 million in revenue and $13.2 million in Adjusted EBITDA. The forecast assumes the successful closure and integration of the Paradium.AI partnership and represents the company's first full year of at-scale platform operations.

8:06 AM ET 8-K
Loan & Debt Solaris Energy Infrastructure, Inc. SEI

Solaris Energy Infrastructure $1B Debt Financing

Solaris Energy Infrastructure, LLC, a subsidiary of Solaris Energy Infrastructure, Inc., announced a private placement offering of $1.0 billion in Senior Notes due 2032. The company intends to use the net proceeds for general corporate purposes, growth capital expenditures, and related fees and expenses.

Value
$1B
Term
2032
8:06 AM ET 8-K
Executive Compensation Scynexis Inc SCYX

Scynexis Executive Compensation

SCYNEXIS appointed Steven K. Burke, M.D., to its Board of Directors and the Nominating and Corporate Governance Committee. Dr. Burke will receive an annual cash retainer of $45,000 plus $5,000 for committee service, along with initial equity grants of 5,750 stock options and 5,750 restricted stock units. The appointment adds deep nephrology drug development expertise as the company prepares to advance its ADPKD candidate, SCY-770, into Phase 2 trials.

Counterparty
Steven K. Burke, M.D.
8:05 AM ET 8-K
Clinical Trial Data PDS Biotechnology Corp PDSB

PDS Biotechnology Clinical Trial Data

PDS Biotechnology announced the publication of Phase 2 VERSATILE-002 trial results in JAMA Oncology, evaluating PDS0101 in combination with pembrolizumab for HPV16-positive head and neck cancer. The study reported a median overall survival of 39.3 months in ICI-naïve patients, significantly exceeding the 17.9 months typically seen with standard-of-care pembrolizumab. The treatment was well-tolerated with a 13.8% rate of Grade 3 or higher treatment-related adverse events.

Counterparty
JAMA Oncology
8:04 AM ET Form 4
Insider Buying MasterCraft Boat Holdings, Inc. MCFT

MasterCraft Boat Holdings Director Peter G. Leemputte Buys $25K of Stock

Peter G. Leemputte, Director, bought 1,265 shares of MasterCraft Boat Holdings, Inc. at $19.73 a share, worth $25K in total on Sep 18, 2026. Shares held after the trade: 38,132 (+3.4%).

Value
$25K
Shares
1,265
Price
$19.73
Role
Director
Holding change
+3.4%
Trade date
Sep 18, 2026
8:01 AM ET 8-K
Business Update Filana Therapeutics, Inc. FLNA

Filana Therapeutics Business Update

The FDA has lifted a full clinical hold on Filana Therapeutics' IND application for simufilam, allowing the company to proceed with a Phase 2a proof-of-concept study in TSC-related epilepsy. The company expects to begin patient screening by Q1 2027 and has already completed trial-readiness activities including site identification and drug supply preparation.

Counterparty
FDA
8:01 AM ET 8-K
Business Update Contango Silver & Gold Inc. CTGO

Contango Silver & Gold Business Update

Contango Silver & Gold Inc. announced the completion of an updated Technical Report Summary (TRS) and Mineral Resource Estimate for its Kitsault Valley Project. The report, effective September 11, 2026, provides updated data on indicated and inferred mineral resources to support continued evaluation of potential underground extraction at the site.

8:01 AM ET 8-K
Business Update Knightscope, Inc. KSCP

Knightscope Business Update

Knightscope reported approximately $27 million in estimated renewals, bookings, and client awards across 109 contracts and seven vertical markets. The total includes a $17 million estimated three-year master services agreement with a multinational industrial client and a $5.8 million award from a national retailer. The update follows the company's launch of its 'Autonomous Security Force' at the GSX 2026 conference.

Term
May 20, 2026 through September 18, 2026
8:00 AM ET 8-K
Other 8-K Filing Jersey Mike's Subs Inc. JMKE

Jersey Mike's Subs Other 8-K Filing

Affiliates of Blackstone, the majority owners of Jersey Mike's Subs Inc., entered into margin loan agreements for aggregate borrowings of approximately $1.09 billion. To secure the loans, Blackstone pledged 172,621,820 total shares and units, representing approximately 54.3% of the company's outstanding stock. While Jersey Mike's is not a party to the debt, a default by Blackstone could result in a foreclosure on the pledged collateral and a subsequent change in control of the company.

Counterparty
Blackstone Inc.
8:00 AM ET 8-K
Leadership Change Fiserv Inc FISV

Fiserv Leadership Change

Adam L. Rosman resigned as Chief Administrative Officer and Chief Legal Officer of Fiserv, Inc., effective September 30, 2026. Eric C. Nelson, the company's current General Counsel and Secretary, will succeed him as Chief Legal Officer on October 1, 2026.

8:00 AM ET Form 4
Insider Buying Duos Technologies Group, Inc. DUOT

Duos Technologies Group Insider James Craig Nixon Buys $49.3K of Stock

James Craig Nixon bought 5,764 shares of Duos Technologies Group, Inc. at $8.50 to $8.60 a share (average $8.55) in 2 transactions, worth $49.3K in total on Sep 18, 2026. Shares held after the trade: 84,523 (+3.6%).

Value
$49.3K
Shares
5,764
Average price
$8.55
Holding change
+3.6%
Trade date
Sep 18, 2026
7:56 AM ET 8-K
M&A Deal Iron Horse Acquisition II Corp. IRHO

Iron Horse Acquisition II Signs $250M M&A Deal with Electra Vehicles, Inc.

Iron Horse Acquisition II Corp. (IRHO) provided a status update on its pending merger with Electra Vehicles, Inc., a transaction valued at over $250 million. The update highlights commercial milestones achieved since the April 2026 agreement, including new partnerships with Mooving, Omega Seiki Mobility, and Propel Industries, as the companies work toward a closing in the second half of 2026.

Value
$250M
Counterparty
Electra Vehicles, Inc.
7:51 AM ET 8-K
Dividend Blackstone Private Credit Fund BCRED

Blackstone Private Credit Fund Dividend

Blackstone Private Credit Fund declared monthly distributions for September 2026 of $0.1800 per share for Class I, S, and D common shares, payable to shareholders of record as of September 30, 2026. The fund also reported an aggregate net asset value (NAV) of approximately $43.2 billion and a total investment portfolio fair value of $76.4 billion as of August 31, 2026.

7:43 AM ET Form 4
Insider Selling Similarweb Ltd. SMWB

Similarweb CEO Or Offer Sells $580K of Stock

Or Offer, CEO, sold 69,700 shares of Similarweb Ltd. at $8.25 to $8.40 a share (average $8.32) in 2 transactions, worth $580K in total between Sep 18, 2026 and Sep 21, 2026. Shares held after the trade: 4,107,681 (-0.8%).

Value
$580K
Shares
69,700
Average price
$8.32
Role
CEO
Holding change
-0.8%
Trade date
Sep 18, 2026 to Sep 21, 2026
7:31 AM ET 8-K
M&A Deal Beam Global BEEM

Beam Global M&A Deal with Unnamed European drone technology company

Beam Global has signed a non-binding letter of intent to acquire a European drone technology company that develops AI-enhanced software and hardware. If completed, Beam intends to manufacture the target's U.S. Department of War conditionally approved drone systems in its existing U.S. and European factories. The deal aims to transform Beam into a vertically integrated drone and software provider, leveraging its existing battery manufacturing expertise and government customer base.

Counterparty
Unnamed European drone technology company
7:30 AM ET 8-K
Contract Win Greenbrier Companies Inc GBX

Greenbrier Companies Wins $600M Contract from Saudi Railway Company

Greenbrier Companies announced orders for 3,400 new railcars valued at approximately $600 million during its fiscal fourth quarter. The orders include 780 units for the Saudi Railway Company (SAR), marking Greenbrier's first sale of intermodal units to SAR and expanding their long-term infrastructure partnership in Saudi Arabia.

Value
$600M
Counterparty
Saudi Railway Company (SAR)
7:28 AM ET Form 4
Insider Buying Village Farms International, Inc. VFF

Village Farms International CEO Michael A. Degiglio Buys $101K of Stock

Michael A. Degiglio, CEO, bought 35,000 shares of Village Farms International, Inc. at $2.89 a share, worth $101K in total on Sep 22, 2026. Shares held after the trade: 9,730,775 (+0.4%).

Value
$101K
Shares
35,000
Price
$2.89
Role
CEO
Holding change
+0.4%
Trade date
Sep 22, 2026
7:12 AM ET 8-K
Leadership Change Group 1 Automotive Inc GPI

Group 1 Automotive Leadership Change

Group 1 Automotive has appointed Benjamin Hart, an analyst at major shareholder Conifer Management, to its Board of Directors, effective November 1, 2026. The appointment is part of a stockholder agreement that includes customary standstill and voting provisions, requiring Conifer to vote in favor of Board recommendations. In connection with the appointment, the Board will expand from ten to eleven members.

Counterparty
Conifer Management, L.L.C.
7:12 AM ET 8-K
Capital Raise Willis Lease Finance Corp WLFC

Willis Lease Finance Capital Raise of $35M

Willis Lease Finance Corporation entered into a purchase agreement to issue 1,750,000 shares of newly issued 8.09% Series B Preferred Stock to the Development Bank of Japan Inc. in a private placement. The transaction is expected to generate gross proceeds of approximately $35 million to support the company's global aviation services platform and business growth.

Value
$35M
Counterparty
Development Bank of Japan Inc.
7:09 AM ET 8-K
M&A Deal Lexeo Therapeutics, Inc. LXEO

Lexeo Therapeutics Signs $8.3M M&A Deal with Mantle Therapeutics Inc.

Lexeo Therapeutics entered into a definitive agreement to acquire Mantle Therapeutics for an upfront purchase price of $5.3 million in cash and $3.0 million in common stock. The deal includes up to $12.0 million in contingent development and regulatory milestone payments plus a $1.0 million cash payment upon specific events, aimed at expanding Lexeo's Friedreich ataxia (FA) pipeline with new CNS-targeted modalities.

Value
$8.3M
Counterparty
Mantle Therapeutics Inc.
7:09 AM ET 8-K
Clinical Trial Data Celldex Therapeutics, Inc. CLDX

Celldex Therapeutics Clinical Trial Data

Celldex reported positive topline results from its Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 trials of barzolvolimab in chronic spontaneous urticaria (CSU), meeting the primary and all key secondary endpoints. The data showed rapid and sustained efficacy through 24 weeks, including in patients refractory to omalizumab, with a favorable safety profile. The company plans to submit a Biologics License Application (BLA) to the FDA in 2027.

Earnings call
Sep 22, 2026, 8:00 AM ET

“The results from our two Phase 3 EMBARQ-CSU trials showed efficacy that is best-in-disease in CSU. We believe barzolvolimab is well-positioned to address large CSU populations of high unmet need—as a first-line therapy for patients with severe CSU or angioedema, and as the second-line advanced therapy of choice.”

Anthony Marucci, Co-Founder, President, and Chief Executive Officer at Celldex

“Barzolvolimab continued to show unprecedented complete response rates across the overall studies and demonstrated strong differentiation in patient populations underserved by existing therapies, including those with severe disease or angioedema, and those whose disease is refractory to omalizumab.”

Diane Young, MD, Senior Vice President and Chief Medical Officer of Celldex
7:09 AM ET 8-K
M&A Deal Ligand Pharmaceuticals Inc LGND

Ligand Pharmaceuticals Signs $23M M&A Deal with Sydnexis, Inc.

Ligand Pharmaceuticals acquired royalty and milestone payment rights for Ryjunea from Sydnexis for $23 million upfront. Ryjunea is a treatment for pediatric myopia licensed to Santen Pharmaceutical in the EMEA region, where it is already approved. Ligand will receive tiered royalties ranging from low-double-digits to high-teens on net sales in those territories.

Value
$23M
Counterparty
Sydnexis, Inc.
7:06 AM ET 8-K
Clinical Trial Data Viking Therapeutics, Inc. VKTX

Viking Therapeutics Clinical Trial Data

Viking Therapeutics announced positive topline results from a maintenance study of its GLP-1/GIP agonist VK2735, demonstrating that less frequent dosing (monthly and every other week) effectively maintained weight loss. Subjects receiving weekly 17.5 mg doses achieved 22% placebo-adjusted weight loss at Week 33, and the drug showed excellent tolerability with GI adverse event rates similar to placebo during the maintenance phase.

Earnings call
Sep 29, 2026, 8:00 AM ET

“The results of our innovative maintenance dosing study continue to demonstrate the significance of VK2735’s unique and differentiated half-life and PK profile, which appear to enable an effective new approach to achieving and maintaining the weight loss goals of patients living with obesity.”

Brian Lian, Ph.D., chief executive officer of Viking

“We believe this dose-ranging study clearly demonstrated the potential viability of novel, extended dosing approaches for maintenance following induction with an incretin-based therapy.”

Brian Lian, Ph.D., chief executive officer of Viking
7:06 AM ET 8-K
Business Update Tonix Pharmaceuticals Holding Corp. TNXP

Tonix Pharmaceuticals Holding Business Update

Tonix Pharmaceuticals announced a new agreement with a major pharmacy benefit manager to provide coverage for TONMYA to approximately 21 million Medicare Part D beneficiaries. This expansion brings the total commercial and government payer coverage for the fibromyalgia treatment to approximately 166 million individuals, or 53% of the total U.S. population.

7:06 AM ET 8-K
Leadership Change Cypherpunk Technologies Inc. CYPH

Cypherpunk Technologies Leadership Change

Cypherpunk Technologies appointed Amanda Fabiano, a veteran digital asset mining executive, to its Board of Directors as a Class III director. Mrs. Fabiano will receive an initial grant of 150,000 RSUs and an annual grant of 100,000 RSUs as part of her compensation package. The appointment coincides with the company's operational launch of its Zcash mining fleet, which recently generated over 3,000 ZEC for its treasury.

Counterparty
Amanda Fabiano
Term
through 2029 Annual Meeting

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.